BB BIOTECH AG - Mar 4, 2025 Form SCHEDULE 13G/A Schedule Report for Esperion Therapeutics, Inc. (ESPR)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Esperion Therapeutics, Inc. Common Stock
Symbol: ESPR
Shares outstanding: 198M shares
Disclosed Ownership: 9.69M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 3/10/2025, 11:12 AM
Date of event: Mar 4, 2025
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	4.9%	9.69M	0	9.69M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	4.9%	9.69M	0	9.69M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority